HD-OPM Archive
Topics › Statins

Switching from rosuvastatin to pitavastatin removed a statin-related A1C rise in one case

Louis Nervegna · Jun 04, 2026 · ♥ 6 reactions · 19 comments · original Facebook post
StatinsInsulin resistance & diabetes
AI summary & key facts

Louis comments on a video of a doctor whose A1C rose slightly on rosuvastatin and normalized on pitavastatin. He notes this is a reasonable option for lower-risk people sensitive to glucose effects, but rosuvastatin has stronger large-RCT evidence in high-risk patients, so switching should not be taken lightly.

He saw a small increase in his A1C on rosuvastatin.

This disappeared once he switched to pitavastatin.

This is a good option for people who are especially sensitive to blood sugar increases on statins, like he appears to be.

It’s important to point out that rosuvastatin is the better drug for people at high risk. The evidence from large RCT’s is stronger. That’s why it is used so often in cardiology. So this kind of switch should not be taken lightly in people at high risk. Lower risk people (like him) have more flexibility.

▶Video · YouTube · Nutrition Made Simple!The Common Pill That Raises your Risk of Diabetes (And How to Avoid it)Connect with me: IG:@gilcarvalho.md TT:@nutrition.made.simple Animations: Even Topland @toplandmedia References: Statins lower heart attacks, strokes, death: benefits vs risk of diabetes: Pitavastatin Disclaimer: The contents of this video are for informational purposes only and are not intended to be medical advice, diagnosis, or treatment, nor to replace…youtu.be

#statindiabetesHD #statinsHD #a1cHD #glucoseHD #pitavastatinHD #rosuvastatinHD #insulinresistanceHD #diabetesHD

← newer: Lowering IGF1 extends lifespan in mice, so be wary of 'anti-older: Age is a far stronger heart disease risk factor than cholest →